Thomas Mckee

8PUBLICATIONS
64CO-AUTHORS
Haematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 16, 2024
Effectiveness of fractionated rituximab in preventing tumor lysis syndrome in aggressive B-cell lymphoma: Insights from real-life clinical practice.

Jasmine Mohamad, Antonin Bouroumeau, Thomas A McKee

|Jul 24, 2024
Targeting ferritinophagy impairs quiescent cancer stem cells in acute myeloid leukemia in vitro and in vivo models.

Clement Larrue, Sarah Mouche, Paolo Angelino

|Mar 21, 2024
High Concordance of Different Assays in the Determination of Homologous Recombination Deficiency-Associated Genomic Instability in Ovarian Cancer.

Nicole Pfarr, Karin von Schwarzenberg, Dario Zocholl

|Aug 03, 2023
<i>CXCL9:SPP1</i> macrophage polarity identifies a network of cellular programs that control human cancers.

Ruben Bill, Pratyaksha Wirapati, Marius Messemaker

|Jun 26, 2023
Normalized LST Is an Efficient Biomarker for Homologous Recombination Deficiency and Olaparib Response in Ovarian Carcinoma.

Yann Christinat, Liza Ho, Sophie Clément

|Oct 14, 2022
FOLFOXIRI Resistance Induction and Characterization in Human Colorectal Cancer Cells.

George M Ramzy, Laura Boschung, Thibaud Koessler

Pageof 2

Frequent Collaborators

2 joint publications

Yann Christinat

1 joint publications

Valérie Dutoit

1 joint publications

Jimmy Stalin

1 joint publications

Beat A Imhof